Intriguingly, FINs appear to alter NRF2 levels themselves: the class 1 ferroptosis inducer erastin appeared to decrease NRF2 protein levels in pancreatic cancer and head and neck cancer cells (166), yet increased NRF2 levels in hepatocellular carcinoma cells (147). The gene discussed is NFE2L2; the disease is familial pancreatic carcinoma.